This guideline is the basis of QS48.
This guideline should be read in conjunction with PH12.
Ov Overview erview
This guideline covers identifying and managing depression in children and young people aged between 5 and 18 years. Based on the stepped care model, it aims to improve recognition and assessment and promote effective treatments for mild, moderate and severe depression.
Introduction Introduction
Recommendations on psychological therapies and antidepressants have been added to and updated in sections 1.5 and 1.6. The addendum contains details of the methods and evidence used to update these recommendations.
This guideline covers the identification and treatment of depression in children (5-11 years) and young people (12-18 years) in primary, community and secondary care. Depression is a broad diagnosis that can include different symptoms in different people. However, depressed mood or loss of pleasure in most activities, are key signs of depression. Depressive symptoms are frequently accompanied by symptoms of anxiety, but may also occur on their own. The International Statistical Classification of Diseases (ICD-10) uses an agreed list of 10 depressive symptoms, and divides depression into 4 categories: not depressed (fewer than 4 symptoms), mild depression (4 symptoms), moderate depression (5 to 6 symptoms), and severe depression (7 or more symptoms, with or without psychotic symptoms). For a diagnosis of depression, symptoms should be present for at least 2 weeks and every symptom should be present for most of the day.
For the purposes of this guideline, the management of depression has been divided into the following categories as defined by the ICD-10: mild depression moderate and severe depression severe depression with psychotic symptoms.
However, it is not clear whether the severity of depression can be understood in a single symptom count. Family context, previous history, and the degree of associated impairment are all important in helping to assess depression. Because of this, it is important to assess how the child or young person functions in different settings (for example, at school, with peers and with family), as well as asking about specific symptoms of depression.
Be aware of or suspect abuse as a contributory factor to or cause of the symptoms or signs of depression in children. Abuse may also coexist with depression. See the NICE guideline on child maltreatment for clinical features that may be associated with maltreatment.
This section has been agreed with the Royal College of Paediatrics and Child Health.
Recommendations about medicines
The guideline will assume that prescribers will use a medicine's summary of product characteristics to inform decisions made with individual patients.
This guideline recommends some medicines for indications for which they do not have a UK marketing authorisation at the date of publication, if there is good evidence to support that use.
The prescriber should follow relevant professional guidance, taking full responsibility for the decision. The patient (or those with authority to give consent on their behalf) should provide informed consent, which should be documented. See the General Medical Council's Good practice in prescribing and managing medicines and devices for further information. Where recommendations have been made for the use of medicines outside their licensed indications ('off-label use'), these medicines are marked with a footnote in the recommendations.
Depression in children and young people: identification and management (CG28) If a young person is moving between paediatric and adult services, care should be planned and managed according to the best practice guidance described in the Department of Health's Transition: getting it right for young people.
Adult and paediatric healthcare teams should work jointly to provide assessment and services to young people with depression. Diagnosis and management should be reviewed throughout the transition process, and there should be clarity about who is the lead clinician to ensure continuity of care.
Depression in children and young people: identification and management (CG28)
K Ke ey priorities for implementation y priorities for implementation
The following recommendations were identified as priorities for implementation in the 2005 guideline and have not been changed in the 2015 update.
Assessment and coordination of care Assessment and coordination of care
When assessing a child or young person with depression, healthcare professionals [1] should routinely consider, and record in the patient's notes, potential comorbidities, and the social, Attention should be paid to the possible need for parents' own psychiatric problems (particularly depression) to be treated in parallel, if the child or young person's mental health is to improve. If such a need is identified, then a plan for obtaining such treatment should be made, bearing in mind the availability of adult mental health provision and other services.
[2005] [2005] Step 1: Detection and risk profiling
Step 1: Detection and risk profiling Step 2: Recognition
Step 2: Recognition Step 3: Mild depression
Step 3 See appendix A for the glossary definition of healthcare professionals as used in this guideline.
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Recommendations Recommendations
The following guidance is based on the best available evidence. Depression in children and young people: identification and management (CG28) Depression in children and young people: identification and management (CG28) 
Stepped care
The stepped-care model of depression draws attention to the different needs that depressed children and young people have -depending on the characteristics of their depression and their personal and social circumstances -and the responses that are required from services. It provides a framework in which to organise the provision of services that support both healthcare Depression in children and young people: identification and management (CG28) professionals and patients and their parent(s) or carer(s) in identifying and accessing the most effective interventions (see Table 1 ).
T Table 1 The stepped-care model able 1 The stepped-care model The guidance follows these five steps.
1. Detection and recognition of depression and risk profiling in primary care and community settings.
2. Recognition of depression in children and young people referred to CAMHS.
3. Managing recognised depression in primary care and community settings -mild depression.
4. Managing recognised depression in tier 2 or 3 CAMHS -moderate to severe depression.
5. Managing recognised depression in tier 3 or 4 CAMHS -unresponsive, recurrent and psychotic depression, including depression needing inpatient care.
Each step introduces additional interventions; the higher steps assume interventions in the
1. 3 Step 1: Detection, risk profiling and referral Depression in children and young people: identification and management (CG28) 1. 4 Step 2: Recognition Depression in children and young people: identification and management (CG28)
1. 5 Step 3: Mild depression Depression in children and young people: identification and management (CG28) 1.6.4.10 Sertraline or citalopram should only be used when the following criteria have been met [5] .
The child or young person and their parent(s) or carer(s) have been fully involved in discussions about the likely benefits and risks of the new treatment and have been
provided with appropriate written information. This information should cover the rationale for the drug treatment, the delay in onset of effect, the time course of treatment, the possible side effects, and the need to take the medication as prescribed;
it should also include the latest patient information advice from the relevant regulatory authority.
The child or young person's depression is sufficiently severe and/or causing sufficiently serious symptoms (such as weight loss or suicidal behaviour) to justify a trial of another antidepressant.
There is clear evidence that there has been a fair trial of the combination of fluoxetine and a psychological therapy (in other words that all efforts have been made to ensure adherence to the recommended treatment regimen).
There has been a reassessment of the likely causes of the depression and of treatment resistance (for example other diagnoses such as bipolar disorder or substance abuse).
There has been advice from a senior child and adolescent psychiatrist -usually a consultant.
Depression in children and young people: identification and management (CG28) , medication should be continued for at least 6 months after remission (defined as no symptoms and full functioning for at least 8 weeks).
[ Depression in children and young people: identification and management (CG28) 1.6.9 1.6.9 Recurrent depression and relapse pre Recurrent depression and relapse prev vention ention Depression in children and young people: identification and management (CG28) 
Terms used in this guideline
Activ Active listening e listening A way of listening that focuses entirely on what the other person is saying and confirms understanding of both the content of the message and the emotions and feelings underlying the message to ensure that understanding is accurate.
Adherence Adherence The behaviour of taking medicine according to treatment dosage and schedule as intended by the prescriber. In this guideline, the term adherence is used in preference to the term Depression in children and young people: identification and management (CG28) compliance, but is not synonymous with concordance, which has a number of different uses and meanings.
Adv Adverse drug reaction erse drug reaction Any undesirable experience that results from the administration of a pharmacologically active agent.
Bipolar disorder
Bipolar disorder This condition is also known as manic depression. It is an illness that affects mood, causing a person to switch between feeling very low (depression) and very high (mania).
CAMHS CAMHS Child and Adolescent Mental Health Service(s).
CAMHS link work CAMHS link worker er See Primary mental health work Primary mental health worker er Care Progr Care Programme Approach ( amme Approach (CP CPA) A) Introduced in 1991, this approach was designed to ensure that different community services are coordinated and work together towards a particular person's care. This approach requires that professionals from the health authority and local authority get together to arrange care, and applies to all patients accepted for care by the specialist mental health services.
Child Child An individual aged 5-11 years.
Child and Adolescent Psy Child and Adolescent Psychiatric Assessment ( chiatric Assessment (CAP CAPA) A) An interviewer-based diagnostic interview with versions for use with children and their parent(s).
Cognitiv Cognitive beha e behaviour vioural ther al therap apy ( y (CBT) CBT) A range of behavioural and cognitive behavioural therapies, in part derived from the cognitive behavioural model of affective disorders, in which the patient works collaboratively with a therapist using a shared formulation to achieve specific treatment goals. These may include recognising the impact of behavioural and/or thinking patterns on feeling states and encouraging alternative cognitive and/or behavioural coping skills to reduce the severity of target symptoms and problems.
Con Conv versational technique
ersational technique This term is used in the guideline to emphasise the importance of a two-way communication. A collaboration between patient and healthcare professional aims to ensure that the patient feels able to express their feelings in the healthcare setting safe in the knowledge that their healthcare professional will listen.
Depression ( Depression unresponsiv Depression unresponsive to treatment e to treatment Depression that has failed to respond to two or more antidepressants taken at an adequate dose for an adequate duration given sequentially.
Dysphoria Dysphoria An emotional state characterised by malaise, anxiety, depression or unease.
Dysth Dysthymia ymia A chronic depression of mood which does not currently fulfil the criteria for recurrent depressive disorder, of mild or moderate severity, in terms of either severity or duration of individual episodes. There are variable phases of mild depression and comparative normality.
Despite tiredness, feeling down and not enjoying much, people with dysthymia are usually able to cope with everyday life.
Effectiv Effectiveness eness The extent to which a specific intervention, when used under ordinary circumstances, does what it is intended to do. Clinical trials that assess effectiveness are sometimes called management trials.
Efficacy Efficacy The extent to which an intervention produces a beneficial result under ideal conditions.
Clinical trials that assess efficacy are sometimes called explanatory trials and are restricted to participants who fully cooperate. The randomised controlled trial is the accepted 'gold standard' for evaluating the efficacy of an intervention.
Electrocon Electroconvulsiv vulsive ther e therap apy (ECT) y (ECT) A therapeutic procedure in which an electric current is briefly applied to the brain to produce a seizure. This is used for treatment of severe depression symptoms or to ease depression that isn't responding well to other forms of treatment. It is sometimes called convulsive therapy, electroshock therapy or shock therapy.
Family ther Family therap apy y Family therapy sessions based on systemic, cognitive behavioural or psychoanalytic principles, which may include psychoeducational, problem-solving and crisis management work, and might involve specific interventions with a depressed child or young person.
Guided self-help Guided self-help A self-administered intervention designed to treat depression, which makes use of a range of books or a self-help manual that is based on an evidence-based intervention and is designed specifically for the purpose.
Guideline De Guideline Dev velopment Group ( elopment Group (GDG) GDG) The group of academic experts, clinicians and service user representatives responsible for developing the guideline.
Guideline implementation Guideline implementation Any intervention designed to support the implementation of guideline recommendations.
Guideline recommendation Guideline recommendation A systematically developed statement that is derived from the best available research evidence, using predetermined and systematic methods to identify and evaluate evidence relating to the specific condition in question. Primary mental health workers tend to operate in tiers 1 and 2. In some parts of the UK, including
Scotland, this has led to the establishment of PMHW posts. In other areas the role has been developed, but delivered in a variety of ways. In some cases, workers are employed specifically to deliver primary mental health work, whilst in others, this work is achieved through an extension of pre-existing professional roles.
Psy Psychoanalytic/psy choanalytic/psychodynamic child psy chodynamic child psychother chotherap apy y Psychodynamic interventions are defined as psychological therapies derived from a psychodynamic/psychoanalytic model, and where:
1. Therapist and patient explore and gain insight into conflicts and problem behaviours, modes of thought and relating and how these are represented in current situations and relationships including the therapy relationship (for example, transference and counter-transference).
2. This leads to patients being given an opportunity to explore through play, drawing, talking and behaviour, feelings and conscious and unconscious conflicts, originating in the past or in learnt behaviour. The technical focus is on interpreting and working through conflicts and recurrent problematic areas of behaviour and relating as they manifest in the treatment situation.
3. Therapy is non-directive and recipients are not taught specific skills (such as thought monitoring, re-evaluating, or problem solving).
Psy Psychological ther chological therapies apies A group of treatment methods that involve psychosocial rather than physical intervention. They include cognitive behavioural therapy, family therapy, systemic family therapy, non-directive supportive therapy, psychodynamic psychotherapy, group psychotherapy, Depression in children and young people: identification and management (CG28) counselling, art therapy, interpersonal psychotherapy, guided self-help and any other form of treatment that aims to be helpful through the communication of thoughts and feelings in the presence of a therapist, who works with the material using a systematic framework for understanding and responding to it.
Racial identity status Racial identity status An individual's perception of himself or herself as belonging to a racial group; also the beliefs, morals and attitudes that are shared with a particular racial group in contrast with other groups. It has been suggested that racial identity is integral to personality and is a key dynamic factor in psychotherapeutic dyads.
Randomisation Randomisation A method used to generate a random allocation sequence, such as using tables of random numbers or computer-generated random sequences. The method of randomisation should be distinguished from concealment of allocation, because if the latter is inadequate, selection bias may occur despite the use of randomisation. For instance, a list of random numbers may be used to randomise participants, but if the list were open to the individuals responsible for recruiting and allocating participants, those individuals could influence the allocation process, either knowingly or unknowingly.
Randomised controlled trial (R Randomised controlled trial (RCT) CT) (also termed r randomised clinical trial andomised clinical trial) An experiment in which investigators randomly allocate eligible people into groups to receive or not to receive one or more interventions that are being compared. The results are assessed by comparing outcomes in the different groups. Through randomisation, the groups should be similar in all aspects apart from the treatment they receive during the study.
Recurrent depression
Recurrent depression The development of a depressive disorder in a person who has previously suffered from depression.
Relapse Relapse The reappearance of disease signs and symptoms after apparent remission. The definitions of relapse used in the review in the guideline were those adopted by the individual studies and varied between studies.
Remission Remission Diminution or disappearance of symptoms.
Risk profiling Risk profiling A structured assessment and analysis of those factors in a child or young person's environment and history that are known to increase the risk of depression.
Screening Screening Screening is defined by the Guideline Development Group as a simple test performed on a large number of people to identify those who have depression.
Self-help Self-help Any activity or lifestyle choice that an individual makes in the belief that it will confer therapeutic benefit. Subsyndromal depression (subthreshold depression) Subsyndromal depression (subthreshold depression) Depressive symptoms that fail to meet the criteria for major depressive disorder. This type of depression is not covered by this guideline.
Suicidal ideation
Suicidal ideation Thoughts about suicide or of taking action to end one's own life.
Tier Tier 1 1 Primary care services including GPs, paediatricians, health visitors, school nurses, social workers, teachers, juvenile justice workers, voluntary agencies and social services.
Tier Tier 2 CAMHS 2 CAMHS Services provided by professionals relating to workers in primary care including clinical child psychologists, paediatricians with specialist training in mental health, educational psychologists, child and adolescent psychiatrists, child and adolescent psychotherapists, counsellors, community nurses/nurse specialists and family therapists.
Tier Tier 3 CAMHS 3 CAMHS Specialised services for more severe, complex or persistent disorders including child and adolescent psychiatrists, clinical child psychologists, nurses (community or inpatient), child and adolescent psychotherapists, occupational therapists, speech and language therapists, art, music and drama therapists, and family therapists.
Tier Tier 4 CAMHS 4 CAMHS Tertiary-level services such as day units, highly specialised outpatient teams and inpatient units. Council's Good practice in prescribing and managing medicines and devices for further information.
[3]
At the time of publication (March 2015), fluoxetine was the only antidepressant with UK marketing authorisation for use in this indication for children and young people aged 8 to 18. Interv Interventions that must ( entions that must (or must not) be used or must not) be used
We usually use 'must' or 'must not' only if there is a legal duty to apply the recommendation.
Occasionally we use 'must' (or 'must not') if the consequences of not following the recommendation could be extremely serious or potentially life threatening.
Interv Interventions that should ( entions that should (or should not) be used -a 'strong' recommendation or should not) be used -a 'strong' recommendation
We use 'offer' (and similar words such as 'refer' or 'advise') when we are confident that, for the vast majority of patients, an intervention will do more good than harm, and be cost effective. We use similar forms of words (for example, 'Do not offer…') when we are confident that an intervention will not be of benefit for most patients.
Interv Interventions that could be used entions that could be used
We use 'consider' when we are confident that an intervention will do more good than harm for most patients, and be cost effective, but other options may be similarly cost effective. The choice of intervention, and whether or not to have the intervention at all, is more likely to depend on the patient's values and preferences than for a strong recommendation, and so the healthcare professional should spend more time considering and discussing the options with the patient.
Recommendation wording in guideline updates Recommendation wording in guideline updates Depression in children and young people: identification and management (CG28)
